Spots Global Cancer Trial Database for penile cancer
Every month we try and update this database with for penile cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination | NCT03856437 | Cervical Cancer Anal Cancer Penile Cancer | HPV vaccination... | 18 Years - 99 Years | University of Maryland, College Park | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Inguinal Lymphadenectomy for Penile Cancer | NCT05887921 | Penile Cancer Lymph Node Meta... Sentinel Lymph ... Surgical Compli... | Inguinal Lympha... | 18 Years - 80 Years | Azienda Ospedaliera Città della Salute e della Scienza di Torino | |
| Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS) | NCT04231981 | Penile Cancer | INCMGA0012 | 18 Years - | MedSIR | |
| T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | NCT02280811 | Vaginal Cancer Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal C... | Fludarabine Cyclophosphamid... E6 TCR Aldesleukin | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | NCT05686226 | Cervical Cancer Throat Cancer Oropharynx Canc... Anal Cancer Vulva Cancer Vaginal Cancer Penile Cancer Metastatic Canc... HPV-Related Mal... HPV-Related Car... HPV-Related Cer... HPV-Related Squ... HPV-Related Ade... HPV Positive Or... HPV-Associated ... HPV-Related Ade... HPV-Related End... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... HPV Positive Re... | E7 TCR-T cells | 18 Years - | Rutgers, The State University of New Jersey | |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer | NCT04475016 | Penile Cancer | Albumin-Bound P... Ifosfamide Cisplatin Nimotuzumab Triprilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma | NCT02837042 | Penile Squamous... | Pembrolizumab | 18 Years - | University of Alabama at Birmingham | |
| Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma | NCT03774901 | Penile Cancer Penile Neoplasm... Penile Squamous... | Avelumab | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Development of Diagnostics and Treatment of Urological Cancers | NCT02994758 | Prostate Carcin... Kidney Cancer Urothelial Carc... Testicular Canc... Penile Cancer | Personalised tr... | 18 Years - | Helsinki University Central Hospital | |
| Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer | NCT05842031 | Penile Cancer | Quality of Life... Patient Educati... Symptom Managem... | 18 Years - | M.D. Anderson Cancer Center | |
| Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | NCT00066391 | Penile Cancer | cisplatin irinotecan hydr... neoadjuvant the... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | NCT01209325 | Anal Cancer Nonneoplastic C... Penile Cancer Precancerous Co... | quadrivalent hu... laboratory biom... | 13 Years - 26 Years | AIDS Malignancy Consortium | |
| The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma | NCT05447273 | Penile Cancer | Multi-parametri... | - | Oslo University Hospital | |
| S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) | NCT00058448 | Penile Cancer | docetaxel | 18 Years - | SWOG Cancer Research Network | |
| TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer | NCT04475016 | Penile Cancer | Albumin-Bound P... Ifosfamide Cisplatin Nimotuzumab Triprilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma | NCT03774901 | Penile Cancer Penile Neoplasm... Penile Squamous... | Avelumab | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions | NCT05662839 | Penile Cancer | Cytological Bru... | 18 Years - | The Christie NHS Foundation Trust | |
| Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma | NCT03774901 | Penile Cancer Penile Neoplasm... Penile Squamous... | Avelumab | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention | NCT03346915 | Human Papilloma... Cervical Cancer Human Papilloma... Oropharyngeal C... Vaginal Cancer Vulvar Cancer Anal Cancer Penile Cancer | WoW and BNI | 9 Years - 65 Years | Boston Medical Center | |
| Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old | NCT05518201 | Penile Cancer Anal Cancer PIN-1 PIN-2 PIN-3 AIN1 AIN2 AIN3 Genital Wart | Placebo among 1... Placebo among 9... | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer | NCT01526486 | Melanoma Merkel Cell Car... Squamous Cell C... Penile Carcinom... Urethral Carcin... Extramammary Pa... Scrotal Carcino... Anal Cancer Vulvar Cancer Skin Cancer Lymphadenopathy | Videoscopic pro... Open, tradition... | 18 Years - 80 Years | Emory University | |
| Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations | NCT04357873 | Squamous Cell L... Vulvar Cancer Penile Cancer Cervix Cancer Head and Neck S... Anal Cancer | pembrolizumab; ... | 18 Years - | UNICANCER | |
| Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS) | NCT04231981 | Penile Cancer | INCMGA0012 | 18 Years - | MedSIR | |
| Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma | NCT02837042 | Penile Squamous... | Pembrolizumab | 18 Years - | University of Alabama at Birmingham | |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | NCT01585428 | Cervical Cancer Oropharyngeal C... Vaginal Cancer Anal Cancer Penile Cancer | Fludarabine Cyclophosphamid... Young TIL Aldesleukin | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | NCT05899361 | Urologic Cancer Urologic Neopla... Bladder Cancer Prostate Cancer Testicular Canc... Kidney Cancer Urethral Cancer Penile Cancer | Electromagnetic... Ultrasound | 18 Years - | Dana-Farber Cancer Institute | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | NCT02280811 | Vaginal Cancer Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal C... | Fludarabine Cyclophosphamid... E6 TCR Aldesleukin | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
| Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions | NCT05662839 | Penile Cancer | Cytological Bru... | 18 Years - | The Christie NHS Foundation Trust | |
| Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | NCT00512096 | Penile Cancer | Ifosfamide Paclitaxel (Tax... Cisplatin | 14 Years - | M.D. Anderson Cancer Center | |
| TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer | NCT06415318 | Penile Cancer | Paclitaxel + If... | 18 Years - 75 Years | Sun Yat-sen University | |
| A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | NCT05899361 | Urologic Cancer Urologic Neopla... Bladder Cancer Prostate Cancer Testicular Canc... Kidney Cancer Urethral Cancer Penile Cancer | Electromagnetic... Ultrasound | 18 Years - | Dana-Farber Cancer Institute | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue | NCT04574427 | Head and Neck C... Penile Cancer | 18 Years - | The Netherlands Cancer Institute | ||
| Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis | NCT02817958 | Penile Cancer Squamous Carcin... | Chemotherapy TI... | 18 Years - | UNICANCER | |
| Development of Diagnostics and Treatment of Urological Cancers | NCT02994758 | Prostate Carcin... Kidney Cancer Urothelial Carc... Testicular Canc... Penile Cancer | Personalised tr... | 18 Years - | Helsinki University Central Hospital | |
| PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study | NCT03686332 | Penile Cancer | Arm A: Atezoliz... Arm B: Atezoliz... | 18 Years - | The Netherlands Cancer Institute | |
| Lymphedema After Urologic Surgery | NCT05264337 | Urinary Bladder... Prostatic Neopl... Testicular Neop... Penile Cancer | Self-reported l... Dielectric cons... Limb volume | 18 Years - | Vastra Gotaland Region | |
| The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | NCT05739812 | Renal Cell Carc... Adrenal Tumor Nonfunctioning ... Renal Pelvis Ca... Ureteral Tumor Bladder Cancer Prostate Cancer Pelvic Tumor Renal Cyst Duplex Kidney Renal Calculi Ureteral Calcul... Ureteropelvic J... Penile Cancer | telesurgery by ... | 18 Years - 80 Years | The Affiliated Hospital of Qingdao University | |
| Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers | NCT02526316 | HPV-induced Can... | P16_37-63 pepti... P16_37-63 pepti... | 18 Years - | Oryx GmbH & Co. KG | |
| Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer | NCT01526486 | Melanoma Merkel Cell Car... Squamous Cell C... Penile Carcinom... Urethral Carcin... Extramammary Pa... Scrotal Carcino... Anal Cancer Vulvar Cancer Skin Cancer Lymphadenopathy | Videoscopic pro... Open, tradition... | 18 Years - 80 Years | Emory University | |
| Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | NCT00512096 | Penile Cancer | Ifosfamide Paclitaxel (Tax... Cisplatin | 14 Years - | M.D. Anderson Cancer Center | |
| Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old | NCT05518201 | Penile Cancer Anal Cancer PIN-1 PIN-2 PIN-3 AIN1 AIN2 AIN3 Genital Wart | Placebo among 1... Placebo among 9... | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers | NCT02526316 | HPV-induced Can... | P16_37-63 pepti... P16_37-63 pepti... | 18 Years - | Oryx GmbH & Co. KG | |
| Image Guided Penile Cancer Surgery | NCT05376202 | Penile Cancer Margin Assessme... | Cetuximab-IRDye... | 18 Years - | University Medical Center Groningen | |
| Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis | NCT02817958 | Penile Cancer Squamous Carcin... | Chemotherapy TI... | 18 Years - | UNICANCER | |
| Integrated Cancer Repository for Cancer Research | NCT02012699 | Pancreatic Canc... Thyroid Cancer Lung Cancer Esophageal Canc... Thymus Cancer Colon Cancer Rectal Cancer Gastrointestina... Anal Cancer Bile Duct Cance... Duodenal Cancer Gallbladder Can... Gastric Cancer Liver Cancer Small Intestine... Peritoneal Surf... Familial Adenom... Lynch Syndrome Bladder Cancer Kidney Cancer Penile Cancer Prostate Cancer Testicular Canc... Ureter Cancer Urethral Cancer Hypopharyngeal ... Laryngeal Cance... Lip Cancer Oral Cavity Can... Nasopharyngeal ... Oropharyngeal C... Paranasal Sinus... Nasal Cavity Ca... Salivary Gland ... Skin Cancer Central Nervous... Central Nervous... Mesothelioma Breast Cancer Leukemia Melanoma Sarcoma Unknown Primary... Multiple Myelom... Ovarian Cancer Endometrial Can... Vaginal Cancer Neuroendocrine ... Plasma Cell Dys... Healthy Control | 19 Years - 110 Years | University of Nebraska |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
